Sorafenat - Sorafenib |
|
Sorafenat contains sorafenib, which is a small molecular inhibitor of several tyrosine protein kinases. Manufactured By: Natco Pharma Ltd. Indication: Sorafenat is used for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer. Available As: 200 mg tablets. Bottle of 120 Tablets Note: Sorafenat is a prescription drug and should be used under proper medical guidance and advice. |